UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Routine Bile Culture From Liver Donors as Screening of Donor‐Transmitted Infections in Liver Transplantation

Liver transplantation, 2020-09, Vol.26 (9), p.1121-1126

2020

Volltextzugriff (PDF)

Effect of SARS‐CoV‐2 preventive measures on early lung transplant fungal acquisition: An observational study

Transplant infectious disease, 2024-02, Vol.26 (1), p.e14246-n/a

2024

Volltextzugriff (PDF)

Low seroprevalence of SARS‐CoV‐2 antibodies in a liver transplant cohort

Transplant international, 2021-10, Vol.34 (10), p.1908-1913

2021

Volltextzugriff (PDF)

Transplantation of organs from SARS‐CoV‐2‐positive donors: Preliminary experience from Spain

Transplant infectious disease, 2023-02, Vol.25 (1), p.e14008-n/a

2023

Volltextzugriff (PDF)

Long‐term effects of COVID‐19 in solid organ transplantation recipients

Transplant infectious disease, 2021-08, Vol.23 (4), p.e13677-n/a

2021

Volltextzugriff (PDF)

Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature

Transplant infectious disease, 2019-06, Vol.21 (3), p.e13072-n/a

2019

Volltextzugriff (PDF)

Tobramycin Systemic Absorption in Lung Transplant Recipients Treated With Inhaled Tobramycin: A Cohort Study

Transplant international, 2024-03, Vol.37, p.12579-12579

2024

Volltextzugriff (PDF)

Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales

Microbiology spectrum, 2023-10, Vol.11 (5), p.e0213623-e0213623

2023

Volltextzugriff (PDF)

Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis

Antimicrobial agents and chemotherapy, 2016-07, Vol.60 (7), p.4398-4400

2016

Volltextzugriff (PDF)

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study)

Microbiology spectrum, 2022-02, Vol.10 (1), p.e0178421-e0178421

2022

Volltextzugriff (PDF)

Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients

Transplantation reviews (Philadelphia, Pa.), 2023-12, Vol.37 (4), p.100788-100788, Article 100788

2023

Volltextzugriff (PDF)

Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial

Open forum infectious diseases, 2019-06, Vol.6 (6), p.ofz243-ofz243

2019

Volltextzugriff (PDF)

Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study

Archivos de bronconeumología (English ed.), 2021-11, Vol.57 (11), p.690-696

2021

Volltextzugriff (PDF)

Successful liver transplantation despite donor‐transmitted ESBL‐producing Klebsiella pneumoniae infection: Case report and review of the literature

Transplant infectious disease, 2017-10, Vol.19 (5), p.n/a

2017

Volltextzugriff (PDF)

A 72‐Year‐Old Man With Dyspnea, Circumferential Aortic Thickening, and Weight Loss

Arthritis care & research (2010), 2013-12, Vol.65 (12), p.2056-2061

2013

Volltextzugriff (PDF)

Risk of infection associated with new therapies for lymphoproliferative syndromes

Medicina clinica, 2020-02, Vol.154 (3), p.101

2020

Volltextzugriff (PDF)

Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction

Clinical infectious diseases, 2019-09, Vol.69 (7), p.1192-1197

2019

Volltextzugriff (PDF)

New antibiotics for the treatment of infections by multidrug-resistant microorganisms

Medicina clinica, 2020-05, Vol.154 (9), p.351

2020

Volltextzugriff (PDF)

An overview of ceftolozane sulfate + tazobactam for treating hospital acquired pneumonia

Expert opinion on pharmacotherapy, 2020-06, Vol.21 (9), p.1005-1013

2020

Volltextzugriff (PDF)

COVID‐19 in lung transplant recipients: A multicenter study

American journal of transplantation, 2021-05, Vol.21 (5), p.1816-1824

2021

Volltextzugriff (PDF)

Reply to "Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin"

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Volltextzugriff (PDF)

Ceftazidime-Avibactam plus Aztreonam for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria

Antimicrobial agents and chemotherapy, 2022-10, Vol.66 (10), p.e0075122-e0075122

2022

Volltextzugriff (PDF)

CMV-Specific Cell-Mediated Immunity Predicts a High Level of CMV Replication After Prophylaxis Withdrawal in Lung Transplant Recipients

The Journal of infectious diseases, 2021-08, Vol.224 (3), p.526-531

2021

Volltextzugriff (PDF)

Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

Journal of antimicrobial chemotherapy, 2022-04, Vol.77 (5), p.1452-1460

2022

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(65)

Sprache

Spanisch
(6)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(49)
Humans
(37)
Infectious Diseases
(19)
Transplantation
(19)
Microbiology
(15)
Male
(14)
Adult
(13)
Anti-Bacterial Agents - Therapeutic Use
(13)
Immunology
(13)
Transplant Recipients
(13)
Female
(12)
Middle Aged
(12)
Retrospective Studies
(12)
Aged
(10)
Lung Transplantation
(10)
Pharmacology & Pharmacy
(9)
Infection
(7)
Microbial Sensitivity Tests
(7)
Surgery
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Routine Bile Culture From Liver Donors as Screening of Donor‐Transmitted Infections in Liver Transplantation

Effect of SARS‐CoV‐2 preventive measures on early lung transplant fungal acquisition: An observational study

Low seroprevalence of SARS‐CoV‐2 antibodies in a liver transplant cohort

Transplantation of organs from SARS‐CoV‐2‐positive donors: Preliminary experience from Spain

Long‐term effects of COVID‐19 in solid organ transplantation recipients

Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature

Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper

Tobramycin Systemic Absorption in Lung Transplant Recipients Treated With Inhaled Tobramycin: A Cohort Study

Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales

Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study)

Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial

Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study

Successful liver transplantation despite donor‐transmitted ESBL‐producing Klebsiella pneumoniae infection: Case report and review of the literature

A 72‐Year‐Old Man With Dyspnea, Circumferential Aortic Thickening, and Weight Loss

Risk of infection associated with new therapies for lymphoproliferative syndromes

Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction

New antibiotics for the treatment of infections by multidrug-resistant microorganisms

An overview of ceftolozane sulfate + tazobactam for treating hospital acquired pneumonia

COVID‐19 in lung transplant recipients: A multicenter study

Reply to "Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin"

Ceftazidime-Avibactam plus Aztreonam for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria

CMV-Specific Cell-Mediated Immunity Predicts a High Level of CMV Replication After Prophylaxis Withdrawal in Lung Transplant Recipients

Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

Aktive Filter

Suchergebnisse filtern